-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Inozyme Pharma, Inc. quarterly/annual Return On Assets history and growth rate from 2021 to 2023.
- Inozyme Pharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -57 %, a 33.3% decline year-over-year.
- Inozyme Pharma, Inc. annual Return On Assets for 2023 was -40.7 %, a 14.4% increase from 2022.
- Inozyme Pharma, Inc. annual Return On Assets for 2022 was -47.6 %, a 19.4% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)